R&d

We are committed to developing products that improve options and outcomes for women's health care

The building blocks of the MedRing as a Platform

Drug Delivery

Exploratory Phase

Pre-Clinical Development Phase

Clinical Phase II

Clinical Phase III

Clinical Phase II

Overactive bladder (oxybutynin)

Pre-Clinical Development Phase

Hot flush adjuvans, post-breast cancer surgery (oxybutynin)

Hot flush therapy post-menopause

Diabetes

Endometriosis

Parkinson’s tremors

Exploratory Phase

Smoking cessation

Diagnostics

Exploratory Phase

Pre-Clinical Development Phase

Clinical Phase II

Clinical Phase III

Clinical Phase II

Compliance in drug delivery

Pre-Clinical Development Phase

Tumor markers

Post-operative pressure monitoring

Exploratory Phase

Cycle monitoring

Ovulation detection

Glucose sensor

Overactive bladder monitoring

See what we're up to

Check out our most recent updates and milestones to see how close we are to launching the MedRing. 

Get in touch

Koninginnegracht 33
2514 AC The Hague
The Netherlands